Emirates for Pharmaceuticals boosts pharma readiness
The article focuses on the efforts of the Emirates Pharmaceuticals Authority during the first half of 2026 to enhance the pharmaceutical system in the UAE. This was achieved through improving product oversight and health regulation, developing legislation, localizing production, and supporting research and development. The results showed improved safety, quality, and faster supply of innovative treatments to the market, with 942 new medical products approved, advancements in local manufacturing, consolidation of supply channels, and a global position in the approval of new high-quality therapies. Additionally, the authority launched initiatives to promote sustainability and innovation, as the UAE aims to become a regional hub for the pharmaceutical industry and regulation.
Notice: This Is an AI-Generated Summary
Comments (0)